Tel: 0207 848 7297

About the study

The COVID-19 Clinical Neuroscience Study (COVID-CNS) is a £2.3m UKRI study jointly led by researchers at the University of Liverpool and King's College London. Acute neurological and neuropsychiatric complications of COVID-19 affect up to 20-30% of hospitalised patients. In collaboration with CoroNerve and ISARIC-4C study, we will identify these patients, and those that have received the COVID-19 vaccination, and invite them to join COVID-CNS, part of the COVID-19 section of the NIHR BioResource.

Watch the COVID-CNS team discuss the study

The study looks to investigate what is driving brain complications in patients with COVID-19 and why do some people develop neurological or neuropsychiatric symptoms whilst others do not.

Publications Close up edge of colorful magazine stacking with blurry bookshelf background


The COVID-CNS team are actively producing papers for journals with impact; take a look at the most recent articles.

Working groups Working groups

Working groups

COVID-CNS has six working groups focusing on different research areas of brain complications associated with COVID-19.

Patient and public involvement Patient and Public Involvement

Patient and Public Involvement (PPI)

Our PPI panel are helping to shape our research study by sharing the patient’s perspective on COVID-CNS. Find out more from the PPI team.

Latest from @covidcns